Literature DB >> 33409845

Crowdfunding for anticancer therapies: an analysis of non-US GoFundMe pages.

Shahid Iqbal1, Dearbhaile Catherine Collins2.   

Abstract

BACKGROUND: Crowdfunding is the internet practice of funding a project or person by requesting online monetary donations from people. We set out to analyse the current non-US GoFundMe cancer pages in order to get deeper understanding of this unregulated activity.
METHODS: We identified 150 non-US GoFundMe webpages between November 2019 and January 2020. Data collected included clinicopathological details such as age, gender, cancer type and stage of the disease along with other parameters.
RESULTS: Of 150 pages reviewed, 83% requestors were adults, 64% were female and the median age was 33 years (2-60). The majority of requestors had brain cancer, followed by breast cancer and ovarian cancer. The median amount of money requested was €48,205 (€1171-€588,759). The majority of pages were from the UK (59%) and Ireland (16%). Financial support for cancer patients was the largest group identified (25%). Requests for immunotherapy were the second most common (21%) followed by alternative therapies (19%) and funding for anticancer drug not financed by specific health system but approved elsewhere (12%). The largest amount of money requested was for immunotherapy (median €187,064).
CONCLUSION: Our GoFundMe analysis has identified that crowdfunding platforms are predominantly used for requesting financial support, but worryingly, a large proportion are requesting immunotherapy for unlicensed indications and alternative therapies with no evidence. Future efforts to improve patient education, and possibly online donation page regulation, are required to better manage this route of cancer funding.

Entities:  

Keywords:  Cancer; Crowdfunding; GoFundMe

Year:  2021        PMID: 33409845     DOI: 10.1007/s11845-020-02449-3

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  7 in total

1.  Crowdfunding for prostate cancer and breast cancer.

Authors:  Stacy Loeb; Sorab Taneja; Dawn Walter; Sarah Zweifach; Nataliya Byrne
Journal:  BJU Int       Date:  2018-06-13       Impact factor: 5.588

2.  Crowdfunding for Unproven Stem Cell-Based Interventions.

Authors:  Jeremy Snyder; Leigh Turner; Valorie A Crooks
Journal:  JAMA       Date:  2018-05-08       Impact factor: 56.272

3.  Medical Crowdfunding for Scientifically Unsupported or Potentially Dangerous Treatments.

Authors:  Ford Vox; Kelly McBride Folkers; Angela Turi; Arthur L Caplan
Journal:  JAMA       Date:  2018-10-23       Impact factor: 56.272

4.  Medical crowdfunding to access CAR T-cell therapy.

Authors:  Linda D Ho; Sarah O Oso; Aaron D Levine
Journal:  Lancet Oncol       Date:  2019-07-29       Impact factor: 41.316

5.  Risks and benefits of phase 1 oncology trials, 1991 through 2002.

Authors:  Elizabeth Horstmann; Mary S McCabe; Louise Grochow; Seiichiro Yamamoto; Larry Rubinstein; Troy Budd; Dale Shoemaker; Ezekiel J Emanuel; Christine Grady
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

Review 6.  Ethical implications of medical crowdfunding: the case of Charlie Gard.

Authors:  Gabrielle Dressler; Sarah A Kelly
Journal:  J Med Ethics       Date:  2018-05-04       Impact factor: 2.903

7.  Survival of patients in a Phase 1 Clinic: the M. D. Anderson Cancer Center experience.

Authors:  Jennifer Wheler; Apostolia M Tsimberidou; David Hong; Aung Naing; Tiffiny Jackson; Suyu Liu; Lei Feng; Razelle Kurzrock
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

  7 in total
  2 in total

1.  Crowdfunding campaigns for paediatric patients: A cross-sectional analysis of success determinants.

Authors:  Mikołaj Kamiński; Aleksandra Borys; Jan Nowak; Jarosław Walkowiak
Journal:  J Mother Child       Date:  2022-04-30

2.  An overview of Fintech applications to solve the puzzle of health care funding: state-of-the-art in medical crowdfunding.

Authors:  Laura Grassi; Simone Fantaccini
Journal:  Financ Innov       Date:  2022-09-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.